NeoRich BioPharma Tech Co., Limited (NRBP)

NeoRich BioPharma Tech Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net Income	-0.23	-1	-0.57	-0.88	-4.53	-2.44
Other Amortization	-	-	0.07	0.02	0.09	0.33
Asset Writedown & Restructuring Costs	-	-	-	-	-	0.43
Stock-Based Compensation	-	-	0.08	0.46	0.63	0.01
Other Operating Activities	-0.07	0.72	0	-0.27	3.7	1.19
Change in Accounts Receivable	0	0	-0	-0	0	0.01
Change in Inventory	0	0	-0.01	-	-	-
Change in Accounts Payable	0.15	0.13	0.14	0.07	0.15	-0.09
Change in Other Net Operating Assets	0.11	0.12	0.22	0.18	-0.24	-0.06
Operating Cash Flow	-0.03	-0.03	-0.07	-0.43	-0.21	-0.61
Operating Cash Flow Growth	-	-	-	-	-	-

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Short-Term Debt Issued	-	-	-	-	0.03	0.1
Long-Term Debt Issued	-	0.03	0.08	0.14	-	0.6
Total Debt Issued	0.04	0.03	0.08	0.14	0.03	0.7
Short-Term Debt Repaid	-	-	-	-	-0.04	-0.14
Long-Term Debt Repaid	-	-0	-	-0.01	-	-0.03
Total Debt Repaid	-0	-0	-	-0.01	-0.04	-0.17
Net Debt Issued (Repaid)	0.04	0.03	0.08	0.13	-0.01	0.53
Issuance of Common Stock	-	-	-	0.19	0.27	0.04
Other Financing Activities	-	-	-	-	-	-0.01
Financing Cash Flow	0.04	0.03	0.08	0.31	0.26	0.56

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Foreign Exchange Rate Adjustments	-0.01	-0	-0.02	0.1	-0.04	-0.01
Net Cash Flow	0	-0	-0.01	-0.02	0.01	-0.05

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Free Cash Flow	-0.03	-0.03	-0.07	-0.43	-0.21	-0.61
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-1098.63%	-823.64%	-2462.91%	-	-	-
Free Cash Flow Per Share	-0.10	-0.09	-0.32	-2.11	-1.40	-14.81
Levered Free Cash Flow	-0.16	0.79	0.18	-0.17	-1.02	0.59
Unlevered Free Cash Flow	-0.14	0.81	0.19	-0.16	-0.63	0.68

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash Interest Paid	-	-	-	-	-	0
Change in Working Capital	0.26	0.25	0.35	0.24	-0.09	-0.13

Data Source: S&P Global Market Intelligence Last updated: Feb 12, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error